Premier Biomedical (OTCMKTS:BIEI) Stock Crosses Above 50 Day Moving Average – Time to Sell?

Premier Biomedical, Inc. (OTCMKTS:BIEI – Get Free Report)’s stock price crossed above its 50 day moving average during trading on Wednesday. The stock has a 50 day moving average of $0.00 and traded as high as $0.0006. Premier Biomedical shares last traded at $0.0006, with a volume of 15,336,775 shares trading hands.

Premier Biomedical Stock Performance

Get Premier Biomedical alerts:

About Premier Biomedical

(Get Free Report)

Premier Biomedical, Inc is a development-stage biotechnology company focused on researching and developing novel medical treatments. The company has historically described its work as centered on therapies for serious health conditions, including cancer, chronic pain, neurological disorders and substance-use-related conditions.

Premier Biomedical’s research has included the development of proprietary treatment approaches intended to remove or reduce harmful substances in the bloodstream, as well as potential therapeutic products for pain management and other medical applications.

Further Reading

• Five stocks we like better than Premier Biomedical
• AST SpaceMobile’s BlueBird Progress Comes With Several Risks Still Unresolved
• Time to Nibble on MCD Stock After it Enters Oversold Territory?
• McCormick Stock Trades Cheap, Offers Dividend Growth and Unilever Deal Upside
• Corning and AT&T’s $3 Billion Fiber Deal Reveals Where AI Spending Goes Next

Receive News & Ratings for Premier Biomedical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Premier Biomedical and related companies with MarketBeat.com's FREE daily email newsletter.